//
Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk
Qualitative and Mixed Methods Provide Unique Contributions to Outcomes Research
Screening for Atrial Fibrillation With ECG: USPSTF Recommendation
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials